Ginsenoside Rc attenuates DSS-induced ulcerative colitis, intestinal inflammatory, and barrier function by activating the farnesoid X receptor.
Tang K, Kong D, Peng Y, Guo J, Zhong Y, Yu H, Mai Z, Chen Y, Chen Y, Cui T, Duan S, Li T, Liu N, Zhang D, Ding Y, Huang J.
Tang K, et al. Among authors: huang j.
Front Pharmacol. 2022 Oct 28;13:1000444. doi: 10.3389/fphar.2022.1000444. eCollection 2022.
Front Pharmacol. 2022.
PMID: 36386150
Free PMC article.